Efficacy and safety of Simiao pill in the treatment of hyperuricemia
- Conditions
- hyperuricemia
- Registration Number
- ITMCTR2100005345
- Lead Sponsor
- Southern Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
1. In accordance with the diagnostic criteria of hyperuricemia, or conform to the diagnostic criteria of people of good health status;
2. Aged 18 to 30 years male and female;
3. The subjects of hyperuricemia conforms to the clinical syndrome diagnosis standard of damp heat syndrome in traditional Chinese medicine;
4. The subjects are informed and voluntarily signed the informed consent.
1. Living with a serious adverse lifestyle;
2. With any infection in recent four weeks;
3. Pregnant or lactating women, or people who are allergic to the test drug;
4. Subjects who are taking part in other drugs clinical trials;
5. Volunteers whom researchers believe not suitable for the clinical trail with other reasons;
6. Hereditary disease;
7. Use of antibiotics, probiotics, prebiotics, or synbiotics in two months before collection of the fecal sample.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method uric acid production and excretion; the score of damp heat syndrome;uric acid;
- Secondary Outcome Measures
Name Time Method blood lipid;blood glucose;liver function;renal function;